These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19259780)

  • 21. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the recruitment and retention of pharmacists to practice sites in rural and remote areas of New South Wales: a qualitative study.
    Harding A; Whitehead P; Aslani P; Chen T
    Aust J Rural Health; 2006 Oct; 14(5):214-8. PubMed ID: 17032298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
    Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
    Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do pharmacists counsel customers about the effects of sedating antihistamines on driving skills? A survey of community pharmacies in Saudi Arabia.
    Khojah HM
    J Int Med Res; 2019 May; 47(5):2018-2025. PubMed ID: 30885078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Provision of medicines information in Australian community pharmacies.
    Vitry A; Gilbert A; Mott K; Rao D; March G
    Pharm World Sci; 2009 Apr; 31(2):154-7. PubMed ID: 19229651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the prevalence of and factors associated with advice on prescription medicines: A survey of community pharmacies in an English city.
    Rivers PH; Waterfield J; Grootveld M; Raynor DK
    Health Soc Care Community; 2017 Nov; 25(6):1774-1786. PubMed ID: 28486784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOCUMENT: a system for classifying drug-related problems in community pharmacy.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Stafford AC
    Int J Clin Pharm; 2012 Feb; 34(1):43-52. PubMed ID: 22101425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric medication use experiences and patient counseling in community pharmacies: Perspectives of children and parents.
    Abraham O; Brothers A; Alexander DS; Carpenter DM
    J Am Pharm Assoc (2003); 2017; 57(1):38-46.e2. PubMed ID: 27843107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norwegian elderly patients' need for drug information and attitudes towards medication use reviews in community pharmacies.
    Mamen AV; Håkonsen H; Kjome RL; Gustavsen-Krabbesund B; Toverud EL
    Int J Pharm Pract; 2015 Dec; 23(6):423-8. PubMed ID: 25801503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.
    Svarstad BL; Bultman DC; Mount JK
    J Am Pharm Assoc (2003); 2004; 44(1):22-9. PubMed ID: 14965149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical interventions on prescription problems in a Danish pharmacy setting.
    Pottegård A; Hallas J; Søndergaard J
    Int J Clin Pharm; 2011 Dec; 33(6):1019-27. PubMed ID: 22083723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consumer perspectives of expanded practice in rural community pharmacy.
    Taylor S; Cairns A; Glass B
    Res Social Adm Pharm; 2021 Feb; 17(2):362-367. PubMed ID: 32280050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low pharmacist counseling rates in the Kansas City, Missouri, metropolitan area.
    Fritsch MA; Lamp KC
    Ann Pharmacother; 1997 Sep; 31(9):984-91. PubMed ID: 9296236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-provider communication about medication use at the community pharmacy counter.
    van Dijk M; Blom L; Koopman L; Philbert D; Koster E; Bouvy M; van Dijk L
    Int J Pharm Pract; 2016 Feb; 24(1):13-21. PubMed ID: 25988371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of community pharmacies in North West England: an observational study.
    Mackridge AJ; Stokes EC; Gray NJ
    Int J Pharm Pract; 2017 Apr; 25(2):172-175. PubMed ID: 27198475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counseling of children and adolescents in community pharmacies: Results from a 14-day observational study.
    Carpenter DM; Abraham O; Alexander DS; Horowitz K
    J Am Pharm Assoc (2003); 2016; 56(3):266-269.e1. PubMed ID: 27156941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient outcomes following an intervention involving community pharmacists in the management of depression.
    Crockett J; Taylor S; Grabham A; Stanford P
    Aust J Rural Health; 2006 Dec; 14(6):263-9. PubMed ID: 17121506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.